Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
06:50pm, Monday, 15'th Jul 2024
Pfizer (PFE) reachead $29.10 at the closing of the latest trading day, reflecting a +0.62% change compared to its last close.
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
10:01am, Monday, 15'th Jul 2024
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
11:00am, Saturday, 13'th Jul 2024
Over the years, especially the past three, I have become more cautious about the technology sector's blatant overvaluation. Nevertheless, it is difficult to ignore the capabilities of companies such a
Buy These 5 Beaten-Down High-Yield Stocks Before It's Too Late
06:44am, Saturday, 13'th Jul 2024
24/7 Insights Dividend stocks for many reasons often end up as value stocks and that spells opportunity.
2 Pharma Stocks to Buy Hand Over Fist This Month
05:29am, Saturday, 13'th Jul 2024
Pfizer and Bristol Myers have faced issues recently that have led to poor stock market performances. However, both drugmakers are spinning their innovative wheels and look likely to bounce back.
PFE or NVO: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 12'th Jul 2024
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks offers value investors a bett
With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs
12:26pm, Friday, 12'th Jul 2024
Thursday, Pfizer Inc PFE announced it selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist.
Pfizer (PFE) Moves Forward With Once-Daily Obesity Pill Study
11:31am, Friday, 12'th Jul 2024
Pfizer (PFE) is set to move forward with the development of a once-daily formulation of danuglipron, its GLP-1 candidate for obesity.
Pfizer moves forward with once-daily weight-loss pill to compete with Wegovy
07:33pm, Thursday, 11'th Jul 2024
Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday.
Pfizer is far behind weight loss drug race despite pill trial, says Mizuho's Jared Holz
06:52pm, Thursday, 11'th Jul 2024
Jared Holz, Mizuho, joins 'Fast Money' to talk what impact, if any, the Pfizer weight-loss drug trial will have on the stock.
Pfizer moves forward with once-daily version of weight-loss pill after setbacks
05:11pm, Thursday, 11'th Jul 2024
Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw “encouraging” data in an ongoing early-stage study.
Three-Stock Lunch: Apple, Pfizer and Delta Air Lines
03:15pm, Thursday, 11'th Jul 2024
Michael Farr, Hightower Advisors chief investment strategist, joins 'Power Lunch' to discuss stock plays for three stocks.
Final Trades: Pfizer, L3Harris Tech, the RSP and GDX
01:44pm, Thursday, 11'th Jul 2024
The Investment Committee give you their top stocks to watch for the second half.
Pfizer Stock Rises as Company Advances Studies of Once-a-Day Weight-Loss Pill
01:11pm, Thursday, 11'th Jul 2024
Shares of Pfizer (PFE) advanced as the drug maker announced that it was moving forward with research into a potential once-a-day weight-loss pill.
Pfizer advances once-daily weight-loss pill in ongoing study
12:33pm, Thursday, 11'th Jul 2024
Pfizer announced that it's advancing its oral weight-loss treatment, called danuglipron, to the next round in an ongoing study after seeing "encouraging" results.
